X
Dear User,
On May 25, 2018, Regulation (EU) 2016/679 of the European Parliament and of the Council of April 27, 2016 (General Data Protection Regulation) came into force. We encourage you to familiarise yourself with information about the processing of personal data on the PolskieRadio.pl website.
1.The Data Administrator is Polish Radio S.A., based at 77/85 Niepodległości Ave., 00-977, Warsaw.
2.On issues regarding your data, please contact the Data Protection Officer, e-mail: iod@polskieradio.pl, tel. 22 645 34 03.
3.Personal data may be processed for marketing purposes based on consent.
4.Personal data may be shared solely for the purpose of proper implementation of services defined in the privacy policy.
5.Personal data will not be transferred outside the European Economic Area or to an international organisation.
6.Personal data will be stored for 5 years after an account is deactivated, in accordance with the law.
7.You have the right to access your personal data, correct it, to have it moved or deleted, or to limit its processing.
8.You have the right to object to further processing, and in the case of voicing consent to the processing of personal data, you have the right to withdraw your consent. The exercise of the right to withdraw consent does not affect any processing that has already taken place.
9.You have the right to lodge a complaint with the supervisory authority.
10.Polish Radio S.A. declares that no automated decisions are made when personal data is processed, and that profiling is not used.
For more information on this subject, please read our personal data and privacy policy.
I UNDERSTAND
English Section

Polish scientists test anti-coronavirus drugs

14.05.2020 13:00
Polish scientists are starting clinical trials of drugs that could lessen the impact of the COVID-19 disease on infected patients.
Image by Lutz Dieckmann from Pixabay
Image by Lutz Dieckmann from Pixabay Pixabay License

Prof. Jacek Kubica from the Nicolaus Copernicus University in Toruń, north-central Poland, which is carrying out the trials, said the research was focusing on heart drugs that could help in the early stages of the illness caused by the coronavirus.

He added: “We want to take advantage of the side effects (of such drugs) in order to prevent the virus from entering the cells of the body and multiplying in these cells.”

The drugs will be administered to more than 800 patients in the trials, public broadcaster Polish Radio’s IAR news agency reported.

A total of 17,469 people have tested positive for the COVID-19 disease in Poland, with 869 deaths from the coronavirus so far, officials said on Thursday morning.

(pk/gs)

Source: IAR